SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elizabeth A Shephard, Eileen P Treacy, Ian R Phillips, Clinical utility gene card for: Trimethylaminuria – update 2014, European Journal of Human Genetics, 2014,

    CrossRef

  2. 2
    Bogdan Calenic, Anton Amann, Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease, Bioanalysis, 2014, 6, 3, 357

    CrossRef

  3. 3
    Rosalia D’Angelo, Concetta Scimone, Teresa Esposito, Daniele Bruschetta, Carmela Rinaldi, Alessia Ruggeri, Antonina Sidoti, Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report, Journal of Medical Case Reports, 2014, 8, 1, 328

    CrossRef

  4. 4
    Makiko Shimizu, Charles K. Allerston, Elizabeth A. Shephard, Hiroshi Yamazaki, Ian R. Phillips, Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population, British Journal of Clinical Pharmacology, 2014, 77, 5
  5. 5
    R.N. Hines, Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children, International Journal of Pharmaceutics, 2013, 452, 1-2, 3

    CrossRef

  6. 6
    Filipa Ferreira, Sofia Esteves, Lígia S. Almeida, Ana Gaspar, Cláudia Dias da Costa, Patrícia Janeiro, Anabela Bandeira, Esmeralda Martins, Elisa Leão Teles, Paula Garcia, Luísa Azevedo, Laura Vilarinho, Trimethylaminuria (fish odor syndrome): Genotype characterization among Portuguese patients, Gene, 2013, 527, 1, 366

    CrossRef

  7. 7
    Elizabeth A Shephard, Eileen P Treacy, Ian R Phillips, Clinical utility gene card for: Trimethylaminuria, European Journal of Human Genetics, 2012, 20, 3

    CrossRef

  8. 8
    Ronald N. Hines, The ontogeny of drug metabolism enzymes and implications for adverse drug events, Pharmacology & Therapeutics, 2008, 118, 2, 250

    CrossRef

  9. 9
    Jianhua Zhou, Elizabeth A. Shephard, Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3, Mutation Research/Reviews in Mutation Research, 2006, 612, 3, 165

    CrossRef

  10. 10
    Ronald N. Hines, D. Gail McCarver, Pharmacogenomics and the Future of Drug Therapy, Pediatric Clinics of North America, 2006, 53, 4, 591

    CrossRef

  11. 11
    John R Cashman, The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development, Drug Discovery Today, 2004, 9, 13, 574

    CrossRef

  12. 12
    Ana Mazón Ramos, Alberto Gil-Setas, Sara Berrade Zubiri, Trinidad Bandrés Echeverri, Ron Wevers, Udo Engelke, Johannes Zschocke, Trimetilaminuria o síndrome del olor a pescado. Nueva mutación génica y primer caso documentado en España, Medicina Clínica, 2003, 120, 6, 219

    CrossRef

  13. 13
    Sevasti B Koukouritaki, Pippa Simpson, Catherine K Yeung, Allan E Rettie, Ronald N Hines, Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression, Pediatric Research, 2002, 51, 2, 236

    CrossRef

  14. 14
    Deborah M. Lambert, Orval A. Mamer, Beverley R. Akerman, Luc Choinière, Daniel Gaudet, Pavel Hamet, Eileen P. Treacy, In Vivo Variability of TMA Oxidation Is Partially Mediated by Polymorphisms of the FMO3 Gene, Molecular Genetics and Metabolism, 2001, 73, 3, 224

    CrossRef

  15. 15
    J Zschocke, D Kohlmueller, E Quak, T Meissner, GF Hoffmann, E Mayatepek, Mild trimethylaminuria caused by common variants in FM03 gene, The Lancet, 1999, 354, 9181, 834

    CrossRef